🔎 Trials Near Me

Akèy › Lukemi lenfositè kwonik › Virginia › Richmond

Etid klinik pou Lukemi lenfositè kwonik nan Richmond, VA

6 etid pou Lukemi lenfositè kwonik ap chèche patisipan nan sit nan ak bò kote Richmond (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Ap rekriteFaz 1/2
  • Virginia Commonwealth University Massey Cancer Center, Richmond
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05006716

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Ap rekriteFaz 3
  • VCU Massey Comprehensive Cancer Center, Richmond
Laj 65 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Bon Secours Richmond Community Hospital, Richmond
  • Bon Secours Saint Mary's Hospital, Richmond
  • Bon Secours Cancer Institute at Reynolds Crossing, Richmond
  • ak 3 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Ap rekriteFaz 3
  • VCU Massey Cancer Center at Stony Point, Richmond
  • VCU Massey Comprehensive Cancer Center, Richmond
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT04269902

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Ap rekriteFaz 3
  • Virginia Commonwealth University (VCU) Medical Center ( Site 0030), Richmond
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06136559

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Ap rekriteFaz 3
  • Virginia Cancer Institute, Richmond
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05254743

Etid Lukemi lenfositè kwonik nan lòt vil

Lòt etid nan Richmond

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.